Skip to main content
. 2019 Oct 31;9:1079. doi: 10.3389/fonc.2019.01079

Figure 3.

Figure 3

Western blotting on protein expressions of ERα, GPR30, EGFR, pEGFR, ERK, and pERK. (A) Protein expression in Ishikawa and HEC-1B cells with or without exposure to 10 μM BDE-47. (B) Protein expression in Ishikawa-BDE-47 and HEC-1B-BDE-47 cells treated with or without siERα, and siGPR30. (C) Expression of pEGFR and EGFR in Ishikawa-BDE-47 and HEC-1B-BDE-47 after pEGFR inhibitor (erlotinib) treatment (left). Expression of pERK and total ERK in Ishikawa-BDE-47 and HEC-1B-BDE-47 after pERK inhibitor (DP98059) treatment (right).